1.
Simonneau G, Hoeper MM, Ghofrani HA, Corris PA, Rosenkranz S, GrĂ¼ning E, White J, Mclaughlin VV, Langleben D, Meier C, Busse D, Kleinjung F, Benza RL. Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients. rev. colomb. neumol. [Internet]. 3 de diciembre de 2020 [citado 16 de septiembre de 2021];31(2). Disponible en: https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/451